Final hours! Save up to 55% OFF InvestingProCLAIM SALE

CPE Technology Bhd sets IPO price to raise RM179.58 million on Bursa Malaysia

EditorAmbhini Aishwarya
Published 20/11/2023, 04:36 pm
© Reuters.
BMYS
-

CPE Technology Bhd, an engineering support company, has set its initial public offering (IPO) price at RM1.07 per share as it prepares to go public on December 7. The listing on Bursa Malaysia's Main Market is expected to raise RM179.58 million and value the company at a market capitalization of RM718.31 million, based on an enlarged issued share capital of 671.31 million shares.

Despite a drop in net profit to RM30.29 million for the financial year ended June 30, from RM33.91 million the previous year, the company reported an increase in revenue to RM145.28 million (USD1 = MYR4.6675) in FY2023. This performance comes as CPE Technology continues to serve key markets in the semiconductor, life sciences/medical devices, and sports equipment sectors with a substantial client base in the United States, Singapore, and Malaysia.

The IPO share distribution is structured to cater to various investor groups:

  • Malaysian public subscriptions are set for 33.6 million shares.
  • A Bumiputera investor allocation of 83.9 million shares.
  • Private placements totaling over a hundred million shares for institutional and selected investors.

The proceeds from the IPO are earmarked for several strategic initiatives:

  • Land acquisitions and new plants will receive RM69.6 million.
  • Machinery and equipment purchases are allocated RM32.9 million.
  • Loan repayments will account for RM17.5 million.
  • Working capital needs are budgeted at RM46.9 million.
  • Other capital expenditures will take up RM1.4 million.
  • The estimated listing expenses are projected at RM11.3 million.

This financial strategy highlights CPE Technology's commitment to expanding its operational capabilities and enhancing its competitive edge in the industry. With its upcoming listing, the company is poised for growth as it leverages the capital infusion from public and private investors alike.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.